There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:A61P21/00
Jump to navigation
Jump to search
Subcategories
This category has the following 13 subcategories, out of 13 total.
A
C
E
J
M
P
R
S
T
Pages in category "A61P21/00"
The following 15 pages are in this category, out of 15 total.
1
- 17415589. Compositions and Methods for Enhancing Body Weight and Lean Muscle Mass Using Antagonists Against Leptin Receptor, GDF8 and Activin A simplified abstract (Regeneron Pharmaceuticals, Inc.)
- 18170296. COMPOSITIONS AND METHODS FOR TREATMENT OF SPINAL MUSCULAR ATROPHY simplified abstract (The University of Hong Kong)
- 18289935. COMPOSITION FOR INCREASING MUSCLE MASS simplified abstract (TOHOKU UNIVERSITY)
- 18294594. ENGINEERED MUSCLE TARGETING COMPOSITIONS (MASSACHUSETTS INSTITUTE OF TECHNOLOGY)
- 18294594. ENGINEERED MUSCLE TARGETING COMPOSITIONS (President and Fellows of Harvard College)
- 18383256. AGENTS AND METHODS FOR PREVENTING AND TREATING SKELETAL MUSCLE DISEASES simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18516014. BICYCLIC KETONE COMPOUNDS AND METHODS OF USE THEREOF simplified abstract (Genentech, Inc.)
- 18615080. COMPOSITIONS AND METHODS FOR MUSCLE REGENERATION USING PROSTAGLANDIN E2 (The Board of Trustees of the Leland Stanford Junior University)
- 18918621. DIETARY BUTYRATE (SOCIETE DES PRODUITS NESTLE S.A.)
D
- DNA Storage patent applications on 28th Feb 2025
- DNA Storage patent applications on February 27th, 2025
- DNA Storage patent applications on January 23rd, 2025
- DNA Storage patent applications on January 30th, 2025
- Dyne Therapeutics, Inc. (20250066495). MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING MUSCULAR DYSTROPHY
- Dyne Therapeutics, Inc. (20250066496). MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
